These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Innovative trends in the design of therapeutic trials in psychopharmacology and psychotherapy. Fava GA; Tomba E; Tossani E Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():306-11. PubMed ID: 23123361 [TBL] [Abstract][Full Text] [Related]
5. Pragmatic measures in paediatric psychopharmacology--are we getting it right? Coghill D Eur Neuropsychopharmacol; 2011 Aug; 21(8):571-83. PubMed ID: 21194897 [TBL] [Abstract][Full Text] [Related]
6. Traditional and alternative research designs and methods in clinical pediatric psychopharmacology. Fava M J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1292-303. PubMed ID: 8885583 [TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Klassen AF; Miller A; Fine S Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087 [TBL] [Abstract][Full Text] [Related]
8. An update on publicly funded multisite trials in pediatric psychopharmacology. Vitiello B Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):1-12. PubMed ID: 16321723 [TBL] [Abstract][Full Text] [Related]
9. The EU paediatric regulation: effects on paediatric psychopharmacology in Europe. Stoyanova-Beninska VV; Wohlfarth T; Isaac M; Kalverdijk LJ; van den Berg H; Gispen-de Wied C Eur Neuropsychopharmacol; 2011 Aug; 21(8):565-70. PubMed ID: 20621456 [TBL] [Abstract][Full Text] [Related]
10. From scientific knowledge to the clinical practice of psychopharmacology: can the gap be bridged? Rush AJ; Prien RF Psychopharmacol Bull; 1995; 31(1):7-20. PubMed ID: 7675992 [TBL] [Abstract][Full Text] [Related]
11. Guidelines, algorithms, and evidence-based psychopharmacology training for psychiatric residents. Osser DN; Patterson RD; Levitt JJ Acad Psychiatry; 2005; 29(2):180-6. PubMed ID: 15937265 [TBL] [Abstract][Full Text] [Related]
12. Psychopharmacology of pediatric bipolar disorders in children and adolescents. Thomas T; Stansifer L; Findling RL Pediatr Clin North Am; 2011 Feb; 58(1):173-87, xii. PubMed ID: 21281855 [TBL] [Abstract][Full Text] [Related]
13. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
14. Journal of Child and Adolescent Psychopharmacology. From the editor-in-chief's desk. Koplewicz HS J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):237. PubMed ID: 24945084 [No Abstract] [Full Text] [Related]
15. The case for practical clinical trials in psychiatry. March JS; Silva SG; Compton S; Shapiro M; Califf R; Krishnan R Am J Psychiatry; 2005 May; 162(5):836-46. PubMed ID: 15863782 [TBL] [Abstract][Full Text] [Related]
16. Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda. Connor DF; Carlson GA; Chang KD; Daniolos PT; Ferziger R; Findling RL; Hutchinson JG; Malone RP; Halperin JM; Plattner B; Post RM; Reynolds DL; Rogers KM; Saxena K; Steiner H; J Clin Psychiatry; 2006 May; 67(5):808-20. PubMed ID: 16841631 [TBL] [Abstract][Full Text] [Related]
17. Double-blind versus open evaluations of stimulant drug response in children with attention-deficit hyperactivity disorder. Sprafkin J; Gadow KD J Child Adolesc Psychopharmacol; 1996; 6(4):215-28. PubMed ID: 9231315 [TBL] [Abstract][Full Text] [Related]
18. [Algorithms for the medical treatment of Attention-Deficit/Hyperactivity Disorder with specific co-morbidities]. Frölich J; Lehmkuhl G; Döpfner M Z Kinder Jugendpsychiatr Psychother; 2010 Jan; 38(1):7-20. PubMed ID: 20047172 [TBL] [Abstract][Full Text] [Related]